$0.750000
-0.01-1.34%
At Close: -
$0.759900
0.00991.32%
After Hours: Aug 23, 6:13 PM EDT
15 minutes delayed
X4 Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of X4 Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.07 | $0.01 | -800.0 % |
Mar 2024 | 2024-05-07 | $-0.26 | $-0.16 | -62.5 % |
Dec 2023 | 2024-03-21 | $-0.10 | $-0.15 | 33.3 % |
Sep 2023 | 2023-11-09 | $-0.01 | $-0.15 | 93.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $563.00K | $280.00K | 101.1 % |
Mar 2022 | 2022-05-12 | $0 | $120.00K | -100.0 % |
X4 Pharmaceuticals (XFOR) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.07, which missed the estimate of $0.01.
The Actual Revenue was $563K, which beat the estimate of $280K.
Browse earnings estimates, EPS, and revenue on all stocks.